Chymopapain chemonucleolysis was performed on 100 patients with primary lumbar intervertebral disc disease. The results were compared with those of 174 patients who underwent laminotomy, foraminotomy, and discectomy. Primary lumbar intervertebral disc disease was arbitrarily divided into degenerative, complex, previous surgical, and simple disc syndromes. No difference was seen between chemonucleolysis and surgery in the first three divisions; between 55% and 60% of patients responded successfully to treatment. In the simple disc division 89% of the surgical and 60% of the chemonucleolysis patients had successful results. KEY WORDS 9 chymopapain 9 chemonucleolysis 9 intervertebral disc disease 9 surgery C HEMONUCLEOLYSIS is the technique whereby primary lumbar intervertebral disc disease is treated by the intradiscal injection of the enzyme chymopapain? We are reporting our experiences with the use of chemonucleolysis in the treatment of lumbar disc disease and comparing it to a series treated by orthodox disc surgery.
C
HEMONUCLEOLYSIS is the technique whereby primary lumbar intervertebral disc disease is treated by the intradiscal injection of the enzyme chymopapain? We are reporting our experiences with the use of chemonucleolysis in the treatment of lumbar disc disease and comparing it to a series treated by orthodox disc surgery.
Clinical Material and Methods
The patients were initially seen because of signs and symptoms suggesting intervertebral lumbar disc disease. After an unsuccessful course of conservative treatment, myelography was performed. The procedure of chemonucleolysis was explained and offered as an alternative to surgery. This report compares the first 100 patients who chose chemonucleolysis with 174 patients who chose surgery during the same period of time.
Chemonucleolysis
The patients were given a general anesthetic and hydrocortisone intravenously during the procedure. After intubation, they were placed in a left lateral position and discography by way of a right posterior-lateral approach was performed. Three spaces were usually examined, and up to 4 mg of chymopapain were injected into the appropriate intervertebral disc space. Following the procedure, the patients were allowed to walk as they desired, and were usually discharged from the hospital in 4 to 7 days.
Return to work depended on the patient's symptoms and desires and the difficulty of the work involved, and was usually accomplished within 1 to 3 months of treatment. Postoperative evaluations were made at 3-to 4-week intervals during the first 3 months. Later examinations depended on the patient's symptoms and consent.
Orthodox Surgery
A standardized laminotomy and foraminotomy, with discectomy whenever it was indicated, was performed on the surgical patients. The postoperative management was comparable to that for patients who underwent chemonucleolysis.
Evaluation
Because the syndrome of primary lumbar intervertebral disc disease is difficult to define, we arbitrarily divided both groups of patients into the following four categories for the purpose of evaluation:
Degenerative Disc Syndrome. These patients invariably had chronic back pain of gradual onset. Leg or hip pain, when present, was poorly localized. They showed abnormal postural signs such as lumbar scoliosis, pelvic tilt, paravertebral muscle spasm, loss of lumbar lordosis, and restriction of lumbar spine motion; neurological examination was normal. Plain lumbar spine films showed degenerative changes, while a myelogram was either normal or revealed only a minor midline ventral bulge at a disc space as seen on the lateral view.
Simple Disc Syndrome. These patients had experienced relatively acute back pain, abrupt in onset. Radicular pain or paresthesias as well as postural signs were present, along with the usual neurological signs appropriate to the symptoms. The myelogram invariably revealed a laterally placed lumbar extradural defect at a single disc space appropriate to the neurological findings. Electromyography, when performed, supported the neurological and myelographic finding.
Complex Disc Syndrome. These patients could not be placed in either of the first two categories because of their complex histories of back pain. Leg pain did not appear to be radicular in pattern, and although the postural and neurological examinationswere invariably abnormal, a single root syndrome could not be elicited. The myelogram was usually abnormal, with multiple defects the general rule. Multiroot or diffuse electromyographic abnormalities were often seen.
Previous Surgery. All patients with previous operations for lumbar disc disease were placed in this category, regardless of the level of surgery, the presenting symptoms, the length of time since surgery or the type of surgery performed.
Results
Of the 100 patients receiving chemonucleolysis, 55 were men and 45 women. Their ages ranged from 24 to 62 years. A similar age and sex distribution was seen in the surgical patients. The patients in both groups were followed from 6 months to 2 years. Results are based upon the clinical examination of the patients in the period after treatment. Table 1 summarizes our criteria and results during the immediate period after chemonucleolysis. Most of the improvement occurred while the patients were still in the hospital, and no patient improved after 2 months. Table 2 summarizes our long-term results for the entire group and defines our criteria. * Improved = less symptomatic with an improved examination; mixed = either less symptomatic or an improved examination, but not both; unimproved= neither symptoms nor examination improved. Fifteen percent of the patients became asymptomatic, while an additional 44% continued to have occasional, mild symptoms with no occupational or recreational limitations; placement in either of these two categories indicated successful treatment.
Some occupational and recreational limitations because of symptoms were noted in 22% of the patients, and 19% of the patients received no relief and either quit work altogether because of their symptoms, or required additional surgery. Placement in one of these two categories indicated failure of treatment. Table 3 compares the chemical and surgical results according to the various original evaluation categories. Regardless of the category of disc disease treated by chemonucleolysis, the results were very similar; that is, between 55% and 60% of the patients improved. Except for the category of patients with simple disc syndrome, the results obtained from the two forms of treatment did not differ greatly. But while only 60% of the patients with simple disc syndrome were treated successfully by chemonucleolysis, 89.1% of the patients with surgical treatment of this syndrome had successful results.
Complications
Four of the 100 patients treated by chemonucleolysis had major complications. Two patients developed sensitivity reactions immediately following the injection of chymopapain. One suffered a mild, transient petechial rash and the other developed a more severe reaction characterized by urticaria, marked hypotension, and bronchospasm. By mistake, neither patient was given intravenous steroids during the procedure; both responded well when these were given. A third patient, who was treated for a simple disc syndrome characterized by back and left leg pain, developed a moderately severe causalgic syndrome in the right leg, which eventually after several months responded to alcohol lumbar chemosympathectomy; her original disc symptoms had been alleviated by chemonucleolysis. A fourth patient with complex disc syndrome did not improve after chemonucleolysis. Repeat myelography and surgical exploration revealed a complete block secondary to arachnoiditis in the lumbar region. Two of the 174 surgical patients developed a transient foot drop. A third patient, whose surgery was originally delayed 3 months because of an acute myocardial infarction the night before surgery was to be performed, did not improve postoperatively. A subsequent myelogram and surgical exploration revealed the presence of arachnoiditis at the level of the disc herniation.
Discussion
While intradiscal injection of chymopapain appears to have been effective in the relief of pain in some patients with lumbar disc disease, the reasons for this improvement remain obscure. Chymopapain may hasten, by enzymatic induction, the formation of intradiscal fibrous tissue.' This is consistent with our finding that maximum benefit was obtained within 1 to 2 months after treatment. Chymopapain is known to have a deleterious effect on the microvasculature of small, particularly unmyeLinated, nerve fibers? While being injected into the disc space, chymopapain may be flushed into a torn anulus and affect the function of pain fibers in this region. This might relieve the back pain and referred leg pain thought to occur in certain forms of disc protrusion?
Chymopapain has no known effect upon the anulus or other collagenous material. ~ Thus, the drug is not likely to reach the epidural extension of a partially-extruded fragment, nor would an epidural injection of the drug be expected to reduce significantly the size of an extruded fragment. Case reports in the literature and our own experience suggest that if a patient with a simple disc syndrome fails to respond to chemonucleolysis, surgical exploration is very likely to reveal an extruded fragment?
The drug is extremely simple to use. However, it does have significant major complications attached to its use. Our experience and review of the literature suggest that the major complication rate is in the region of 2% to 3%.5 These complications include arachnoiditis, disc space infection, increased neurological deficit, and significant sensitivity reactions, including death.
Conclusions
Our brief experience suggests that chemonucleolysis may be a relatively effective means of treating some patients with primary lumbar intervertebral disc disease. We feel it should be used before exploratory surgery in most cases: degenerative disc disease without spondylosis, and in patients with the "complex" disc syndrome who do not have a clear-cut surgical indication. We also found it effective in treating patients who have had previous surgery, particularly those who develop a new disc syndrome beneath an apparently intact fusion. However, we are not ready at this time to advocate its universal use as the initial form of postconservative treatment in patients with a "'simple" disc syndrome. This must wait for the development of more sophisticated criteria to separate the patient with the protruded disc from the patient with the extruded disc. In the meantime, randomized or double-blind studies should give further evidence of the true effectiveness and hazards of chymopapain chemonucleolysis in primary lumbar disc disease.
